Selective Reducing Agents
Selective Reducing Agents - Related Videos
10:19
Reducing Agents
0 Views •
2023
Source: Vy M. Dong and Daniel Kim, Department of Chemistry, University of California, Irvine, CA Controlling the reactivity and selectivity during the synthesis of a molecule is very important criteria for chemists. This has led to the development of many reagents that allow chemists to pick and choose reagents suitable for a given task. Quite often, a balance between reactivity and selectivity needs to be achieved. This experiment will use IR spectroscopy to monitor the reaction and to...
01:26
Redox Titration: Other Oxidizing and Reducing Agents
0 Views •
2024
Besides iodine, other oxidizing or reducing agents can serve as titrants in redox titrations. Common oxidizing titrants include KMnO4, cerium(IV), and K2Cr2O7. The choice of oxidizing titrants depends on factors like stability, cost, analyte strength, and reaction rate between the analyte and titrant. KMnO4 is a strong oxidizing titrant that reduces from Mn(VII) to Mn(II) in a highly acidic solution, simultaneously oxidizing the analyte to a higher oxidation state. In this case, KMnO4 acts as a...
03:18
Intrabronchial Delivery: A Technique to Administer an Experimental Agent Selectively Into a Mouse Lung
0 Views •
2023
This video describes an intrabronchial approach to administer an experimental agent selectively into distal right and left lung. In the featured protocol, we will administer bleomycin intrabronchially into a mouse to obtain a better model for pulmonary fibrosis.
15:23
Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
0 Views •
Cited by 27 •
2010
Aptamers are short ribo-/deoxyribo-oligonucleotides selected by in-vitro evolution methods based on affinity for a specific target. Aptamers are molecular recognition tools with versatile therapeutic, diagnostic, and research applications. We demonstrate methods for selection of aptamers for amyloid β-protein, the causative agent of Alzheimer's disease.
11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 5 •
2016
This protocol describes the preparation and characterization of a dendrimeric magnetic resonance imaging (MRI) contrast agent that carries cyclen-based macrocyclic chelates coordinating paramagnetic gadolinium ions. In a series of MRI experiments in vitro, this agent produced an amplified MRI signal when compared to the commercially available monomeric analogue.
FAQs
Selectivity reflects how readily a reagent reacts with one functional group relative to others. Reactivity differences, steric crowding, and electronic interactions influence access and electron or hydride transfer. Together, these factors allow chemists to favor reduction at a chosen site while preserving sensitive bonds elsewhere in the molecule.
Solvent and temperature are part of the reaction conditions that govern electron or hydride transfer. They can influence how strongly the reagent interacts with the substrate and how readily different functional groups react. Controlling these variables helps maintain the intended chemoselectivity, limit competing transformations, and improve the consistency of the desired reduction.
A selective approach is designed to distinguish among reducible groups rather than treat them equivalently. Its value lies in reducing the intended aldehyde, ketone, alkene, or other target while leaving less-reactive or sensitive groups largely unchanged. This control can simplify synthesis by avoiding unnecessary disruption of the molecule's remaining structure.
Begin by identifying the functional group targeted for reduction and noting other reducible or sensitive groups present in the substrate. Then consider reagent reactivity, steric and electronic interactions, solvent, temperature, and related conditions. The chosen combination should favor transfer to the target site while minimizing side reactions and preserving the desired molecular framework.
They are particularly useful when a molecule contains multiple functional groups but only one should be changed. Controlled reduction can reduce the need for protecting-group steps, limit side reactions, and support efficient construction of complex structures. These advantages are relevant to preparing pharmaceuticals, materials, and complex natural products.
A successful strategy gives preferential conversion of the intended functional group while retaining other important bonds and groups. This outcome improves chemoselectivity and can make a synthesis more efficient by reducing unwanted transformations and protecting-group operations. In complex-molecule preparation, preserving sensitive structural features helps maintain a route toward the desired product.